Healthcare

Healthcare expenditure in Singapore is expected to grow, fueled by factors such as rising incomes and a progressively aging population. Diagnostics has emerged as a way for earlier and better identification of diseases to control rising healthcare costs in Singapore. Hence, the country has become a natural choice for many global diagnostic companie...

The healthcare expenditure in Australia in the previous financial year was AUD 170.4 billion, with 10.3% of the gross domestic product (GDP), thereby allowing the country’s healthcare spending to pass the 10% mark for the first time. Healthcare expenditure continues to rise; however, the rate of increase has been curbed in the last few years. At ...

The Asia-Pacific medical imaging industry is in the growth stage. Both established and new medical imaging manufacturers in the region are constantly focusing on innovating new products, while simultaneously looking at ways to reduce the cost incurred for placing their products. Using these manufacturers as partners or joint venture participants of...

21 Aug 2018  |  Asia Pacific

Future of Electronic Medical Record and Electronic Health Record in Asia-Pacific, Forecast to 2023

Product Innovation is the Answer for Sustainability in a Dynamic Market

Infographics

×

The governments and providers in Asia-Pacific (APAC) are focused on reducing medical expenses while improving population health and well-being. A shortage of medical professionals is seen across multiple specialties in various APAC countries; moreover, clinicians are concentrated in urban areas leading to disproportionate clinician–to-patient rat...

Population Health Management (PHM) has many connotations ranging from an ideal or a concept to a real market segment. As a concept it refers to the reduction of disease risk and the attached financial burden at a population level. Execution of the concept entails intricate interaction between telehealth technologies, software solutions, and healthc...

16 Apr 2018  |  Asia Pacific

Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021

Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market

Infographics

×

Key Issues Addressed

Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...

03 Apr 2018  |  Asia Pacific

Asia-Pacific Healthcare Outlook, 2018

The Year of Digital Innovation in Asia-Pacific

Infographics

×

The healthcare industry in Asia-Pacific (APAC) is expected to grow at 12.5% in 2018, making it one of the fastest growing regions in the world, as the global healthcare economy averages an annual growth rate of 4.8%. This positive growth is fuelled by increasing adoption of technology, innovative healthcare access programs, and delivery of care out...

Healthcare expenditure in Malaysia is growing at a higher rate than the expenditure per capita, which translates into better healthcare provision and quality of service in the country. The Malaysian endoscopy devices market is growing under budget constraints that are forcing hospitals to focus on equipment pricing, negotiate better prices, opt fo...

The Indonesian endoscopy devices market is growing. It is driven by rising awareness, the growing demand for better healthcare, and the expanding aging population. Growth is also attributed to the increase in the number of patients and treatment procedures and the anticipated rise in the number of minimally invasive surgeries. The introduction o...